Taken together, these findings suggest that canonical NF-κB signalling was required for the tumour growth human lung cancer cells in in vivo murine xenografts, hence acting as a tumour promoter of human NSCLC growth. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.